Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Demetrius Albanes

Pooling Project of Prospective Studies of Diet and Cancer

Trachea, bronchus and lung Testis Stomach Prostate Pancreas Oesophagus Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Larynx Kidney, renal pelvis and ureter Colorectum Brain, nervous system Bladder

Rachael Ann Clark

CTCL immunobiology: lessons from alemtuzumab

Non-Hodgkin lymphoma

Dongfang Liu

Bispecific cytotoxic lymphocytes in HIV-related lymphoma

Non-Hodgkin lymphoma

Elizaveta V Benevolenskaya

RBP2 Regulation Through Differential Recruitment to Genomic Loci

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma Kaposi sarcoma Hodgkin lymphoma

Pathology

Investigator from French National Centre for Scientific Research (CNRS)

Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma

Non-Hodgkin lymphoma

Pathology